Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants
March 7, 2018 - Online ON CA

Xtalks

fbonilla@xtalks.com
Phone: 4169776555

Presented by Covance Chief Scientific Officer Steve Anderson, PhD, and Covance Global Leader, Precision Medicine, Suso Platero, PhD, this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.

More Information